MiMedx Receives NASDAQ Notice of Late Form 10-Q Filing

MARIETTA, Ga., May 18, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it received written notification, as expected, from the NASDAQ Stock Market that the Company continues to be in...